மார்கஸ் மன்னஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from மார்கஸ் மன்னஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In மார்கஸ் மன்னஸ் Today - Breaking & Trending Today
Die Covid-Impfstoffentwickler Biontech, Moderna & Pfizer zählen zu den Top-Pharmafirmen – entsprechend hoch sind die Bewertungen. Analysten rechnen mit Kursrücksetzern bei den Aktien. ....
Die Covid-Impfstoffentwickler Biontech, Moderna & Pfizer zählen zu den Top-Pharmafirmen – entsprechend hoch sind die Bewertungen. Analysten rechnen mit Kursrücksetzern bei den Aktien. ....
4 Min Read FRANKFURT (Reuters) -Bayer shares dropped as much as 5% on Thursday after a U.S. judge rejected its plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer. The German group called into question the future sale of glyphosate-based products to gardeners in the U.S., and said it would review plans to settle around 30,000 legal claims, after the judge called Bayer’s plan to end years of litigation “unreasonable” on Wednesday. “We will continue to assess financial risks as we move forward,” finance chief Wolfgang Nickl said in an analyst call, when asked if the estimate of the potential financial burden had been revised. ....
New Bayer chairman faces sour investors in his first major tour Details Bayer has lost about a third of its value so far this year EXCERPT: The broadside from multiple shareholders highlights their continued unease with Bayer’s strategy a good two years after the German company bought Monsanto for about $63 billion. That takeover has come to be widely viewed as disastrous because, among other things, it saddled Bayer with massive legal bills tied to Monsanto’s controversial Roundup weedkiller, prompting open rebellion from shareholders against senior management. - Eyk Henning and Tim Loh BNN Bloomberg, Dec 8, 2020 Bayer AG Chairman Norbert Winkeljohann has spent the last few weeks meeting almost two dozen fund managers during his first major tour of the investment community since taking the job in April. The feedback hasn’t been altogether encouraging. ....